Cost & Management of Oncology Combination RegimensOverview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there Share XCost & Management of Oncology Combination Regimenshttps://pharmaphorum.com/oncology/cost-management-of-oncology-combination-regimens/
Amgen’s Repatha cardio data fails to impressRepatha cuts cardio events, but not mortality. Share XAmgen’s Repatha cardio data fails to impresshttps://pharmaphorum.com/news/amgens-repatha-data-fails-to-impress/